Tue.Feb 25, 2025

article thumbnail

Covid, inflation, and Supreme Court blamed for steep drop in Native American medical school enrollment

STAT

The tiny number of Indigenous students in U.S. medical schools has long been a concern, but Native American medical leaders were taken aback to see 22% fewer American Indian or Alaska Native students had enrolled last year when numbers were released in January. “It’s pathetic, isn’t it? It’s so small,” said Donald Warne, a Lakota physician and co-director of the Center for Indigenous Health at the Johns Hopkins Bloomberg School of Public Health, as he looked cl

article thumbnail

Evidence builds behind Regeneron's deafness gene therapy

pharmaphorum

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing

132
132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: What academic research could learn from college athletics

STAT

Since the end of World War II, the business plan of American universities has included two key principles that now are undergoing rapid disruptive change: Student-athletes participate in college sports in exchange for tuition, room, and board. Federal funding for academic research is the primary engine for the nation’s basic science enterprise.

284
284
article thumbnail

Regeneron gene therapy helps deaf children hear in small study

BioPharma Dive

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s treatment, new data show.

130
130
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Eli Lilly to lower price of Zepbound vials, offer more doses

STAT

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from cheap, compounded copies of weight loss medications. Zepbound was originally sold in injectable pens at a list price of about $1,000 per month, but Lilly last year launched the lowest doses of the medication, 2.5 milligrams and 5 milligrams, in vials at $399 and $549 a month.

article thumbnail

Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer

PharmaVoice

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.

130
130

More Trending

article thumbnail

Drug compounders sue FDA over declaration ending Wegovy shortage

BioPharma Dive

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” but in earnings Monday still forecast higher revenue and profits in 2025.

article thumbnail

Opinion: ‘Ultra-processed food’ is too broad a term to be useful

STAT

In recent years, an idea has taken hold across the ideological spectrum: The rise in diabetes and obesity in the United States is attributable to addictive, ultra-processed foods that dominate the American diet. But many people who are enthusiastically objecting to ultra-processed foods have little (if any) understanding of what the phrase means.  Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but there is no clear defi

Diabetes 219
article thumbnail

Incentivizing rare disease R&D is getting tougher, but revamped policies could turn the tide

PharmaVoice

Orphan drug development has long been incentivized by government policy. But as the financial math shifts, so do the risks of bringing rare disease drugs to market.

article thumbnail

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

STAT

Rise and shine, everyone, another busy day is on the way. We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the number of motor vehicles passing by our window. As for us, we are trying to slow things down by engaging in the usual ritual of brewing cups of stimulation.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Greener method for ethylene oxide manufacture identified

European Pharmaceutical Review

Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?

52
article thumbnail

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick recently. It’s a particularly intense flu season right now. Hope everyone is taking care of themselves.

221
221
article thumbnail

ASBM/Ohio State University College of Pharmacy Course Examines Impact of Lowering Interchangeable Biosimilar Standards, IRA

Safe Biologics

On February 20th, Philip Schneider, ASBM Advisory Board Chair, taught a 2-hour class at the Ohio State University College of Pharmacy that examined how recent and proposed biosimilar policy changes may impact pharmacy practice within the biopharmaceutical industry. The module examined three current policy issues related to biosimilars: The likely negative impact of the Inflation Reduction Act’s price-setting on biosimilar development and commercialization; Proposed legislation (such as las

article thumbnail

Wins for bulk milk testing and deafness research

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Everyone’s talking about egg prices, but what I’m most worried about is my apartment’s heating bill. Apparently I’m not alone.

236
236
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract

Pharmaceutical Technology

Samsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous settlement.

article thumbnail

Rishi Sunak joins Prostate Cancer Research as an ambassador

Pharma Times

Former UK PM advocates for national screening programme

96
article thumbnail

Ex-CDER chief Cavazzoni rejoins Pfizer as CMO

pharmaphorum

In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer

95
article thumbnail

Dubai garden blooms with Boehringer Ingelheim’s lung disease campaign

Pharma Times

Awareness of interstitial lung disease raised at Miracle Garden

80
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Rishi Sunak becomes prostate cancer ambassador

pharmaphorum

Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for its campaign for a national screening programme.

72
article thumbnail

Gilead’s lenacapavir applications for HIV gain EMA validation

Pharmaceutical Technology

Gilead Sciences has announced EMA validation for a parallel accelerated review of lenacapavirs MAA and EU-M4all applications.

69
article thumbnail

AI tool detects brain lesions linked to epilepsy

pharmaphorum

Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.

66
article thumbnail

Working Together to Improve the Environment

PharmaTech

Contractors are working with sponsor companies to establish and maintain sustainable manufacturing practices in pharma.

64
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FDA removes clinical hold on Entrada’s Duchenne therapy

Pharmaceutical Technology

Entrada plans to initiate the Phase Ib study of ENTR-601-44 in the US in the first half of next year.

64
article thumbnail

Takeda announces launch of Framework to help support patient access to life-extending combination treatments

Pharmafile

The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination treatments. The post Takeda announces launch of Framework to help support patient access to life-extending combination treatments appeared first on Pharmafile.

59
article thumbnail

Takeda broadens its deal with BridGene for up to $770m

Pharmaceutical Technology

The companies will work together to develop small molecules using BridGenes chemoproteomics platform.

59
article thumbnail

Supplying Sustainably

PharmaTech

Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce green products.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Supply chain uncertainties present opportunities for biopharma couriers in 2025

Pharmaceutical Technology

Rather than dampening demand, pharmaceutical supply challenges present opportunities for innovation to transport specialists.

59
article thumbnail

IMU-856: A Potential Solution for Celiac Patients Facing Cross-Contamination Risks

PharmExec

Daniel Vitt, CEO, Immunic Therapeutics, discusses how IMU-856 could support the challenges of gluten-free diets and cross-contamination risks for celiac disease.

article thumbnail

EMA approves Takeda’s Takhzyro pre-filled pen option for HAE

Pharmaceutical Technology

The EMA has granted approval for an additional 2 mL pre-filled pen option for Takedas Takhzyro, aimed at treating HAE.

59
article thumbnail

FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.